Facial Injectable Market Share, Opportunities, Industry 2030
Facial Injectable Market Share, Opportunities, Industry 2030
Segments - Global Facial Injectable Market by Type (Collagen, Plylactic Acid, Calcium Hydroxylapatite, and Botulinum Toxin), Application(Acne Scar Treatment, Lip Enhancement, and Lipoatrophy Treatment), End-user(Hospitals, Dermatology Experts, and Cosmetic Clinics), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
Upcoming
| Report ID :HC-4777
| 4.2 Rating
| 66 Reviews
| 176 Pages
| Format :
Report Description
The global facial injectable market size was valued at around USD 16.1 billions in 2021 and is projected to reach USD 32 billions by 2030, expanding at a CAGR of around 9 % during the forecast period, 2022 – 2030. The growth of the market is attributed to the increasing awareness regarding facial treatments and growing inclination towards anti-ageing procedures at a high rate.
Increasing focus on physical appearance along with the changing lifestyle has led to the exponential growth in the facial injectable market.
Increasing usage of facial injectable products is the prominent factor driving the global facial injectable market. Facial products like fillers, injections that are used in various modes of operations in order to treat different skin complications and carry out surgeries for facial rejuvenation. Facial injectable products are used to reduce the signs of aging and improve aesthetic beauty. There is a huge demand for facial injectables, due to the increased awareness about facial beauty procedures. Rapid advancements like active injectables in the field of facial injectables led to massive growth in the beauty and personal care sector. The fast-growing population rate across the globe has opened a wide scope for the facial injectable market. There is a corelation between the facial filler substance manufacturing industry and the facial injectable market globally. facial surgeries with innovative minimal invasive procedures are contributing to the popularity of the global facial injectable market. In the cosmetics and personal care sector, there is a huge demand for filler substances, which are making use of soft tissues for introducing minimal invasion. There is a very strongly formed consumer market for combination treatments including surgeries for skin lightening, skin tightening, scar treatments, and anti ageing treatments.
COVID-19 Impact
COVID-19 has affected the cosmetics and personal care sector across the globe by creating upheaval in the facial injectable market growth rate. The restrictions for transport and trading across the globe have led to different challenges for various cosmetic and dermatology clinics. The lockdown led to the decrease in demand for facial injectables, which resulted in a major drop in the revenue generation for the facial injectable market. These facial injectables were not a part of essential needs brackets, due to which it has faced a declination in the market shares.
Market Dynamics
The global facial injectable market research report presents a complete overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges. The global facial injectable market report has up-to-date insights about market dynamics and market scenarios that can shape the overall market performance and output during the forecast period, 2022 to 2030.
Major Trends:
Use of active injectables like less invasive fillers is growing rapidly in the market as an easy option to the smart injectable techniques
In the facial injectable market, the injectable face solutions intending to alleviate indicators of ageing in order to enhance aesthetic appearance by keeping it less invasive and giving good results. Also the cost effective injectables have increased the use of it by making it frequently available in the market.
Key Drivers:
Increasing demand for cosmetics procedures to drive Market
There has been a massive growth in the awareness of aesthetic procedures among the masses in recent years. Increased disposable income and easy availability of economical options for facial procedures are some of the major factors driving the growth of the global facial injectable market. It is also seen that there are categories in the consumers based on different age groups indicating huge market consumer base which in turn reflects the growth of the facial injectable market.
Change in the attitude to look towards cosmetic surgeries has helped to reduce the stigma attached with facial injectables.
Invasive minimalization to hold major market share
Technological advancement in facial fillers procedures with the use of soft tissues used for less invasive techniques that gives more safety than other methods boost the growth in the facial injectable market. The safety measures that are incorporated in the facial Injectable procedures have created a huge demand for skin treatments such as facial fillers.
Existing Challenges:
Risk of skin damages hamper the global facial injectable market growth
There are several risk factors associated with facial injectables such as skin bruises and infections, which are anticipated to restrain the global facial injectable market during the forecast period. There are high chances of skin discoloration in invasive procedures as well. Dermal injectables can leave adverse effects on the skin such as hyper pigmentation, which makes the skin dull and rough. Lack of cost-effective injectables is expected to restrain the growth of the global facial injectable market in the coming years.
Emerging Opportunities:
Exponential growth in the facial injectable offers growth opportunities to the market players
The introduction of new injectable fillers such as synthetic calcium hydroxyl apatite in the facial injectable market is expected to offer new and lucrative opportunities to the market players. The demand for less invasive procedures are anticipated to increase in the coming years as cost-effective methods, which help the growth of the facial injectable market across the globe.
Scope of the Report
The report on the global facial injectable market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Facial Injectable Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2021 |
|
Historic Data |
2019–2020 |
|
Forecast Period |
2022–2030 |
|
Segmentation |
Type (Collagen, Plylactic Acid, Calcium Hydroxylapatite, and Botulinum Toxin), Application (Acne Scar Treatment, Lip Enhancement, and Lipoatrophy Treatment), End-user(Hospitals, Dermatology Experts, and Cosmetic Clinics) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Ipsen Pharma; Revance; Therapeutics,Inc; Sinclair Pharma; Bioplus co.Ltd; Allergan; Anika Therapeutics,Inc |
Market Segment Insights
Botulinium toxin segment to hold key the market share
Type segment is been divided into Collagen, Plylactic acid, calcium hydroxylapatite ,botulinum toxin on the basis of skin treatments and surgeries for face lifting, skin lightening, anti ageing treatments.
On the basis of type, the global facial injectable market is divided into collagen, plylactic acid, calcium hydroxylapatite, and botulinum toxin.
Botulinum toxin segment is one of the leading segment that holds the market share as the botulinium toxin has an ability to relax face muscles by smoothing the skin texture and helping in vanishing wrinkles.
Calcium hydroxylapatite is a bio compatible as well as dermal filler that helps in enhancement of the facial treatments. It facilitats facial fat loss and helps with less invasion techniques.
Acne scar treatment to be observed as a dominant segment in the facial injectables market
Application segment is divided into acne scar treatment, lip enhancement, and lipoatrophy treatment.
Acne scar treatments involve laser use, which delivers heat to the pigmented skin and relies on the production of new healthy collagen. Acne scar treatments done using laser techniques facilitate the generation of new and healthy skin.
End users to hold importance in facial injectable markets
End user segment involves hospitals, dermatology experts, and cosmtic clinics which have significance in the facial injectable market growth. It grows as the consumer base increases depending upon the type of the injectables used in the market.
Asia-Pacific to develop a large scope for the facial injectable market including fillers and skin treatments
Asia-Pacific has structured healthcare infrastructure that offers the facial injectable market a big platform for various advanced skin treatments. Growing awareness of beauty treatments along with the adaption of these treatments naturally in the facial injectable market are main reasons for the growth of the market in the region.
North America is the second largest region majorly because of the population demanding the beauty enhancing techniques so widely in this region where there is wide scope for facial injectable market.
Segments
Type
- Collagen
- Plylactic acid
- calcium hydroxylapatite
- botulinum toxin
Application
- acne scar treatment
- lip enhancement
- lipoatrophy treatment
End user
- Hospitals
- Dermatology experts
- Cosmtic Clinics
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Ipsen Pharma
- Revance
- Therapeutics,Inc
- Sinclair PharmaBioplus co.Ltd
- Allergan
- Anika Therapeutics,Inc
Competitive Landscape
Key players competing in the global facial injectable market are Ipsen Pharma, Revance Therapeutics ,Inc.,Sinclair Pharma, Bioplus co.Ltd, Allergan, Anika Therapeutics, Inc, and others. Some of these major companies have adopted a series of business development strategies including mergers and acquisitions. Entering into partnerships and collaboration, product launches, and production capacity expansion to expand their consumer base and enhance their market share
- On September 2022, Revance Therapeutics, Inc, which is a bio-technology based company, has developed innovative aesthetic and therapeutic solutions such as minimalization of invasive techniques.
- On September 7 2022, Allergen company announced manufacturing of the syringes of JUVEDERM across the globe and it has given the boost for the growth of the facial injectable market.
Frequently Asked Questions
The market is estimated to register CAGR of around 9% during the forecast period.
The global Facial Injectable market size was valued at around USD 16.1 billions in 2021 and is projected to reach USD 32 billions by 2030.
Asia Pacific dominates the global facial injectable market.
Revance Therapeutics,Inc., Ipsen Pharma, Sinclair Pharma, Bioplus co. Ltd, Allergen, and Anika Therapeutics, Inc. are the key players in the global facial injectable market.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Facial Injectable Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Facial Injectable Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Facial Injectable Market - Supply Chain
4.5. Global Facial Injectable Market Forecast
4.5.1. Facial Injectable Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Facial Injectable Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Facial Injectable Market Absolute $ Opportunity
5. Global Facial Injectable Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Facial Injectable Market Size and Volume Forecast by Types
5.3.1. Collagen
5.3.2. Plylactic Acid
5.3.3. Calcium Hydroxylapatite
5.3.4. Botulinum Toxin
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Facial Injectable Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Facial Injectable Market Size and Volume Forecast by Applications
6.3.1. Acne Scar Treatment
6.3.2. Lip Enhancement
6.3.3. Lipoatrophy Treatment
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Facial Injectable Market Analysis and Forecast by End Users
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by End Users
7.2.2. Y-o-Y Growth Projections by End Users
7.3. Facial Injectable Market Size and Volume Forecast by End Users
7.3.1. Hospitals
7.3.2. Dermatology experts
7.3.3. Cosmtic Clinics
7.4. Absolute $ Opportunity Assessment by End Users
7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Facial Injectable Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Facial Injectable Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Facial Injectable Demand Share Forecast, 2019-2026
9. North America Facial Injectable Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Facial Injectable Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Facial Injectable Market Size and Volume Forecast by Types
9.4.1. Collagen
9.4.2. Plylactic Acid
9.4.3. Calcium Hydroxylapatite
9.4.4. Botulinum Toxin
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. North America Facial Injectable Market Size and Volume Forecast by Applications
9.7.1. Acne Scar Treatment
9.7.2. Lip Enhancement
9.7.3. Lipoatrophy Treatment
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. North America Facial Injectable Market Size and Volume Forecast by End Users
9.10.1. Hospitals
9.10.2. Dermatology experts
9.10.3. Cosmtic Clinics
9.11. Basis Point Share (BPS) Analysis by End Users
9.12. Y-o-Y Growth Projections by End Users
9.13. Market Attractiveness/Growth Potential Analysis
9.13.1. By Country
9.13.2. By Product Type
9.13.3. By Application
9.14. North America Facial Injectable Demand Share Forecast, 2019-2026
10. Latin America Facial Injectable Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Facial Injectable Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Facial Injectable Market Size and Volume Forecast by Types
10.4.1. Collagen
10.4.2. Plylactic Acid
10.4.3. Calcium Hydroxylapatite
10.4.4. Botulinum Toxin
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Latin America Facial Injectable Market Size and Volume Forecast by Applications
10.7.1. Acne Scar Treatment
10.7.2. Lip Enhancement
10.7.3. Lipoatrophy Treatment
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Latin America Facial Injectable Market Size and Volume Forecast by End Users
10.10.1. Hospitals
10.10.2. Dermatology experts
10.10.3. Cosmtic Clinics
10.11. Basis Point Share (BPS) Analysis by End Users
10.12. Y-o-Y Growth Projections by End Users
10.13. Market Attractiveness/Growth Potential Analysis
10.13.1. By Country
10.13.2. By Product Type
10.13.3. By Application
10.14. Latin America Facial Injectable Demand Share Forecast, 2019-2026
11. Europe Facial Injectable Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Facial Injectable Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Facial Injectable Market Size and Volume Forecast by Types
11.4.1. Collagen
11.4.2. Plylactic Acid
11.4.3. Calcium Hydroxylapatite
11.4.4. Botulinum Toxin
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Europe Facial Injectable Market Size and Volume Forecast by Applications
11.7.1. Acne Scar Treatment
11.7.2. Lip Enhancement
11.7.3. Lipoatrophy Treatment
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Europe Facial Injectable Market Size and Volume Forecast by End Users
11.10.1. Hospitals
11.10.2. Dermatology experts
11.10.3. Cosmtic Clinics
11.11. Basis Point Share (BPS) Analysis by End Users
11.12. Y-o-Y Growth Projections by End Users
11.13. Market Attractiveness/Growth Potential Analysis
11.13.1. By Country
11.13.2. By Product Type
11.13.3. By Application
11.14. Europe Facial Injectable Demand Share Forecast, 2019-2026
12. Asia Pacific Facial Injectable Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Facial Injectable Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Facial Injectable Market Size and Volume Forecast by Types
12.4.1. Collagen
12.4.2. Plylactic Acid
12.4.3. Calcium Hydroxylapatite
12.4.4. Botulinum Toxin
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Asia Pacific Facial Injectable Market Size and Volume Forecast by Applications
12.7.1. Acne Scar Treatment
12.7.2. Lip Enhancement
12.7.3. Lipoatrophy Treatment
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Asia Pacific Facial Injectable Market Size and Volume Forecast by End Users
12.10.1. Hospitals
12.10.2. Dermatology experts
12.10.3. Cosmtic Clinics
12.11. Basis Point Share (BPS) Analysis by End Users
12.12. Y-o-Y Growth Projections by End Users
12.13. Market Attractiveness/Growth Potential Analysis
12.13.1. By Country
12.13.2. By Product Type
12.13.3. By Application
12.14. Asia Pacific Facial Injectable Demand Share Forecast, 2019-2026
13. Middle East & Africa Facial Injectable Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Middle East & Africa Average Pricing Analysis
13.2. Middle East & Africa Facial Injectable Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Facial Injectable Market Size and Volume Forecast by Types
13.4.1. Collagen
13.4.2. Plylactic Acid
13.4.3. Calcium Hydroxylapatite
13.4.4. Botulinum Toxin
13.5. Basis Point Share (BPS) Analysis by Types
13.6. Y-o-Y Growth Projections by Types
13.7. Middle East & Africa Facial Injectable Market Size and Volume Forecast by Applications
13.7.1. Acne Scar Treatment
13.7.2. Lip Enhancement
13.7.3. Lipoatrophy Treatment
13.8. Basis Point Share (BPS) Analysis by Applications
13.9. Y-o-Y Growth Projections by Applications
13.10. Middle East & Africa Facial Injectable Market Size and Volume Forecast by End Users
13.10.1. Hospitals
13.10.2. Dermatology experts
13.10.3. Cosmtic Clinics
13.11. Basis Point Share (BPS) Analysis by End Users
13.12. Y-o-Y Growth Projections by End Users
13.13. Market Attractiveness/Growth Potential Analysis
13.13.1. By Country
13.13.2. By Product Type
13.13.3. By Application
13.14. Middle East & Africa Facial Injectable Demand Share Forecast, 2019-2026
14. Competition Landscape
14.1. Global Facial Injectable Market: Market Share Analysis
14.2. Facial Injectable Distributors and Customers
14.3. Facial Injectable Market: Competitive Dashboard
14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
14.4.1. Ipsen Pharma
14.4.2. Revance
14.4.3. Therapeutics,Inc
14.4.4. Sinclair PharmaBioplus co.Ltd
14.4.5. Allergan
14.4.6. Anika Therapeutics,Inc
Methodology
Related Reports
Some other reports from this category!
Our Clients
